{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T06:02:19Z","timestamp":1776405739927,"version":"3.51.2"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012543","name":"Youth Science Foundation of Guangxi Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012543","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004607","name":"Natural Science Foundation of Guangxi Province","doi-asserted-by":"publisher","award":["2018GXNSFAA281055"],"award-info":[{"award-number":["2018GXNSFAA281055"]}],"id":[{"id":"10.13039\/501100004607","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012434","name":"Middle-aged and Young Teachers' Basic Ability Promotion Project of Guangxi","doi-asserted-by":"publisher","award":["2022KY0083"],"award-info":[{"award-number":["2022KY0083"]}],"id":[{"id":"10.13039\/501100012434","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.bbrc.2023.01.034","type":"journal-article","created":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T21:25:20Z","timestamp":1675286720000},"page":"96-102","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Glyoxalase 1 inhibitor BBGC suppresses the progression of chronic lymphocytic leukemia and promotes the efficacy of Palbociclib"],"prefix":"10.1016","volume":"650","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6559-7720","authenticated-orcid":false,"given":"Jiameng","family":"Tang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jialing","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zheng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qisheng","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wuning","family":"Mo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2023.01.034_bib1","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.3324\/haematol.2019.236000","article-title":"Chronic lymphocytic leukemia: from molecular pathogenesis to novel therapeutic strategies","volume":"105","author":"Delgado","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.bbrc.2023.01.034_bib2","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/s41408-018-0131-2","article-title":"Chronic lymphocytic leukemia treatment algorithm 2018","volume":"8","author":"Parikh","year":"2018","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.bbrc.2023.01.034_bib3","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1016\/S0140-6736(18)30422-7","article-title":"Chronic lymphocytic leukaemia","volume":"391","author":"Hallek","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.bbrc.2023.01.034_bib4","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3389\/fnins.2015.00023","article-title":"Methylglyoxal, the dark side of glycolysis","volume":"9","author":"Allaman","year":"2015","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.bbrc.2023.01.034_bib5","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1042\/BST20140008","article-title":"Activity, regulation, copy number and function in the glyoxalase system","volume":"42","author":"Rabbani","year":"2014","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.bbrc.2023.01.034_bib6","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1002\/gcc.20784","article-title":"GLO1-A novel amplified gene in human cancer","volume":"49","author":"Santarius","year":"2010","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.bbrc.2023.01.034_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22010310","article-title":"Glyoxalase system in the progression of skin aging and skin malignancies","volume":"22","author":"Yumnam","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2023.01.034_bib8","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1002\/pros.23431","article-title":"High-Level Glyoxalase 1 (GLO1) expression is linked to poor prognosis in prostate cancer","volume":"77","author":"Burdelski","year":"2017","journal-title":"Prostate"},{"key":"10.1016\/j.bbrc.2023.01.034_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/cells8060547","article-title":"Methylglyoxal acts as a tumor-promoting factor in anaplastic thyroid cancer","volume":"8","author":"Antognelli","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.bbrc.2023.01.034_bib10","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1021\/jm00283a009","article-title":"Glyoxalase inhibitors. A possible approach to anticancer agents","volume":"14","author":"Vince","year":"1971","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.bbrc.2023.01.034_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110663","article-title":"Glyoxalase system: a systematic review of its biological activity, related-diseases, screening methods and small molecule regulators","volume":"131","author":"He","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bbrc.2023.01.034_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2019.115243","article-title":"Recent advances in the discovery and development of glyoxalase I inhibitors","volume":"28","author":"Jin","year":"2020","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bbrc.2023.01.034_bib13","doi-asserted-by":"crossref","first-page":"250","DOI":"10.3389\/fgene.2012.00250","article-title":"Role of Glyoxalase 1 (Glo1) and methylglyoxal (MG) in behavior: recent advances and mechanistic insights","volume":"3","author":"Distler","year":"2012","journal-title":"Front. Genet."},{"key":"10.1016\/j.bbrc.2023.01.034_bib14","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1021\/acs.chemrev.8b00201","article-title":"Targeting metalloenzymes for therapeutic intervention","volume":"119","author":"Chen","year":"2019","journal-title":"Chem. Rev."},{"key":"10.1016\/j.bbrc.2023.01.034_bib15","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/0006-2952(96)00059-7","article-title":"Antitumour activity of S-p-bromobenzylglutathione cyclopentyl diester in\u00a0vitro and in\u00a0vivo. Inhibition of glyoxalase I and induction of apoptosis","volume":"51","author":"Thornalley","year":"1996","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbrc.2023.01.034_bib16","doi-asserted-by":"crossref","first-page":"3214","DOI":"10.1182\/blood.V95.10.3214","article-title":"Glyoxalase I is involved in resistance of human leukemia cells to antitumor agent-induced apoptosis","volume":"95","author":"Sakamoto","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2023.01.034_bib17","first-page":"2513","article-title":"Selective activation of apoptosis program by S-p-bromobenzylglutathione cyclopentyl diester in glyoxalase I-overexpressing human lung cancer cells","volume":"7","author":"Sakamoto","year":"2001","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbrc.2023.01.034_bib18","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s40265-015-0379-9","article-title":"Palbociclib: first global approval","volume":"75","author":"Dhillon","year":"2015","journal-title":"Drugs"},{"key":"10.1016\/j.bbrc.2023.01.034_bib19","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.3324\/haematol.2021.279410","article-title":"Rational drug combinations with CDK4\/6 inhibitors in acute lymphoblastic leukemia","volume":"107","author":"Bride","year":"2022","journal-title":"Haematologica"},{"key":"10.1016\/j.bbrc.2023.01.034_bib20","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1182\/blood-2018-11-886457","article-title":"A\u00a0phase 1 trial of ibrutinib plus palbociclib in previously treated mantle cell lymphoma","volume":"133","author":"Martin","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2023.01.034_bib21","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1182\/blood-2015-04-639542","article-title":"Synergistic activity of BET protein antagonist-based combinations in mantle cell lymphoma cells sensitive or resistant to ibrutinib","volume":"126","author":"Sun","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2023.01.034_bib22","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1038\/s41419-018-0968-0","article-title":"CDK4 inhibition diminishes p53 activation by MDM2 antagonists","volume":"9","author":"Sriraman","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbrc.2023.01.034_bib23","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.ccell.2020.01.007","article-title":"CDK4\/6 inhibitors impair recovery from cytotoxic chemotherapy in pancreatic adenocarcinoma","volume":"37","author":"Salvador-Barbero","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbrc.2023.01.034_bib24","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1084\/jem.20120833","article-title":"Cellular origin and pathophysiology of chronic lymphocytic leukemia","volume":"209","author":"Seifert","year":"2012","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.bbrc.2023.01.034_bib25","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1158\/0008-5472.CAN-07-5032","article-title":"Cyclin D1 and CDK4 activity contribute to the undifferentiated phenotype in neuroblastoma","volume":"68","author":"Molenaar","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrc.2023.01.034_bib26","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.molcel.2013.12.002","article-title":"Cyclin-dependent kinase 6 is a chromatin-bound cofactor for NF-kappaB-dependent gene expression","volume":"53","author":"Handschick","year":"2014","journal-title":"Mol. Cell."},{"key":"10.1016\/j.bbrc.2023.01.034_bib27","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1038\/leu.2011.125","article-title":"An eight-gene expression signature for the prediction of survival and time to treatment in chronic lymphocytic leukemia","volume":"25","author":"Herold","year":"2011","journal-title":"Leukemia"},{"key":"10.1016\/j.bbrc.2023.01.034_bib28","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.cell.2013.01.019","article-title":"Evolution and impact of subclonal mutations in chronic lymphocytic leukemia","volume":"152","author":"Landau","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2023.01.034_bib29","doi-asserted-by":"crossref","first-page":"5395","DOI":"10.1038\/s41467-021-25403-y","article-title":"Multi-platform profiling characterizes molecular subgroups and resistance networks in chronic lymphocytic leukemia","volume":"12","author":"Bloehdorn","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrc.2023.01.034_bib30","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.chembiol.2019.05.005","article-title":"Multiomics profiling establishes the polypharmacology of FDA-approved CDK4\/6 inhibitors and the potential for differential clinical activity","volume":"26","author":"Hafner","year":"2019","journal-title":"Cell Chem Biol"},{"key":"10.1016\/j.bbrc.2023.01.034_bib31","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1038\/s41467-020-16588-9","article-title":"Multiplexed relative and absolute quantitative immunopeptidomics reveals MHC I repertoire alterations induced by CDK4\/6 inhibition","volume":"11","author":"Stopfer","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrc.2023.01.034_bib32","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/s41586-018-0623-z","article-title":"Functional genomic landscape of acute myeloid leukaemia","volume":"562","author":"Tyner","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2023.01.034_bib33","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.ccell.2022.07.002","article-title":"Integrative analysis of drug response and clinical outcome in acute myeloid leukemia","volume":"40","author":"Bottomly","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbrc.2023.01.034_bib34","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1182\/blood-2017-09-806398","article-title":"iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL","volume":"131","author":"Hallek","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2023.01.034_bib35","doi-asserted-by":"crossref","first-page":"182","DOI":"10.3892\/etm.2021.11105","article-title":"Hydroxysafflor yellow A attenuates oxidative stress injury-induced apoptosis in the nucleus pulposus cell line and regulates extracellular matrix balance via CA XII","volume":"23","author":"Yang","year":"2022","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.bbrc.2023.01.034_bib36","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1186\/s12864-018-4934-0","article-title":"Transcriptomic analysis reveals candidate genes regulating development and host interactions of Colletotrichum fructicola","volume":"19","author":"Liang","year":"2018","journal-title":"BMC Genom."},{"key":"10.1016\/j.bbrc.2023.01.034_bib37","doi-asserted-by":"crossref","first-page":"4911","DOI":"10.1080\/21655979.2021.1959865","article-title":"Circular RNA Circ_0005564 promotes osteogenic differentiation of bone marrow mesenchymal cells in osteoporosis","volume":"12","author":"Liu","year":"2021","journal-title":"Bioengineered"},{"key":"10.1016\/j.bbrc.2023.01.034_bib38","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/s12943-020-01269-4","article-title":"CircECE1 activates energy metabolism in osteosarcoma by stabilizing c-Myc","volume":"19","author":"Shen","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bbrc.2023.01.034_bib39","series-title":"R: A Language and Environment for Statistical Computing","author":"Team","year":"2021"},{"key":"10.1016\/j.bbrc.2023.01.034_bib40","doi-asserted-by":"crossref","DOI":"10.3390\/nu12051319","article-title":"Cyanidin attenuates methylglyoxal-induced oxidative stress and apoptosis in INS-1 pancreatic beta-cells by increasing glyoxalase-1 activity","volume":"12","author":"Suantawee","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.bbrc.2023.01.034_bib41","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s12020-020-02191-x","article-title":"Inhibition of thioredoxin 2 by intracellular methylglyoxal accumulation leads to mitochondrial dysfunction and apoptosis in INS-1 cells","volume":"68","author":"Liu","year":"2020","journal-title":"Endocrine"},{"key":"10.1016\/j.bbrc.2023.01.034_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.108855","article-title":"Methylglyoxal in combination with 5-Fluorouracil elicits improved chemosensitivity in breast cancer through apoptosis and cell cycle inhibition","volume":"114","author":"Ghosh","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bbrc.2023.01.034_bib43","article-title":"Methylglyoxal scavengers attenuate angiogenesis dysfunction induced by methylglyoxal and oxygen-glucose deprivation","volume":"2022","author":"Chen","year":"2022","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.bbrc.2023.01.034_bib44","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/0145-2126(95)00162-X","article-title":"Effect of methylglyoxal on human leukaemia 60 cell growth: modification of DNA G1 growth arrest and induction of apoptosis","volume":"20","author":"Kang","year":"1996","journal-title":"Leuk. Res."},{"key":"10.1016\/j.bbrc.2023.01.034_bib45","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1038\/s41598-018-37937-1","article-title":"Methylglyoxal down-regulates the expression of cell cycle associated genes and activates the p53 pathway in human umbilical vein endothelial cells","volume":"9","author":"Braun","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrc.2023.01.034_bib46","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.1080\/15384101.2020.1825203","article-title":"Mapping metabolic oscillations during cell cycle progression","volume":"19","author":"Roci","year":"2020","journal-title":"Cell Cycle"},{"key":"10.1016\/j.bbrc.2023.01.034_bib47","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1016\/j.molcel.2022.06.030","article-title":"Lactate is an epigenetic metabolite that drives survival in model systems of glioblastoma","volume":"82","author":"Torrini","year":"2022","journal-title":"Mol. Cell."},{"key":"10.1016\/j.bbrc.2023.01.034_bib48","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3727\/096504022X16442289212164","article-title":"Lactate maintains BCR\/abl expression and signaling in chronic myeloid leukemia cells under nutrient restriction","volume":"29","author":"Silvano","year":"2022","journal-title":"Oncol. Res."},{"key":"10.1016\/j.bbrc.2023.01.034_bib49","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.cmet.2016.08.011","article-title":"LDHA-associated lactic acid production blunts tumor immunosurveillance by T and NK cells","volume":"24","author":"Brand","year":"2016","journal-title":"Cell Metabol."},{"key":"10.1016\/j.bbrc.2023.01.034_bib50","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1038\/s41592-022-01523-1","article-title":"Cyclic immonium ion of lactyllysine reveals widespread lactylation in the human proteome","volume":"19","author":"Wan","year":"2022","journal-title":"Nat. Methods"},{"key":"10.1016\/j.bbrc.2023.01.034_bib51","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/s41586-019-1678-1","article-title":"Metabolic regulation of gene expression by histone lactylation","volume":"574","author":"Zhang","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2023.01.034_bib52","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s12964-015-0114-x","article-title":"L- and D-lactate enhance DNA repair and modulate the resistance of cervical carcinoma cells to anticancer drugs via histone deacetylase inhibition and hydroxycarboxylic acid receptor 1 activation","volume":"13","author":"Wagner","year":"2015","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.bbrc.2023.01.034_bib53","article-title":"D-lactate increases cytokine production in bovine fibroblast-like synoviocytes via MCT1 uptake and the MAPK, PI3K\/akt, and NFkappaB pathways","volume":"10","author":"Manosalva","year":"2020","journal-title":"Animals (Basel)"},{"key":"10.1016\/j.bbrc.2023.01.034_bib54","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/S1470-2045(20)30475-7","article-title":"Biomarker-driven therapies for previously treated squamous non-small-cell lung cancer (Lung-MAP SWOG S1400): a biomarker-driven master protocol","volume":"21","author":"Redman","year":"2020","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.bbrc.2023.01.034_bib55","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/S1470-2045(19)30405-X","article-title":"Palbociclib and cetuximab in platinum-resistant and in cetuximab-resistant human papillomavirus-unrelated head and neck cancer: a multicentre, multigroup, phase 2 trial","volume":"20","author":"Adkins","year":"2019","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.bbrc.2023.01.034_bib56","doi-asserted-by":"crossref","first-page":"e1864","DOI":"10.1634\/theoncologist.2020-0681","article-title":"Phase II trial of palbociclib in patients with advanced esophageal or gastric cancer","volume":"25","author":"Karasic","year":"2020","journal-title":"Oncol."},{"key":"10.1016\/j.bbrc.2023.01.034_bib57","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1001\/jamaoncol.2016.0264","article-title":"Progression-free survival among patients with well-differentiated or dedifferentiated liposarcoma treated with CDK4 inhibitor palbociclib: a phase 2 clinical trial","volume":"2","author":"Dickson","year":"2016","journal-title":"JAMA Oncol."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X23000657?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X23000657?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T12:27:48Z","timestamp":1757766468000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X23000657"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":57,"alternative-id":["S0006291X23000657"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2023.01.034","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glyoxalase 1 inhibitor BBGC suppresses the progression of chronic lymphocytic leukemia and promotes the efficacy of Palbociclib","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2023.01.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}